DocSym
β
Searchsearch
Search
(P04.4) Fetus and newborn affected by maternal use of drugs of addiction
More details coming soon
328 392 in individuals diagnosis fetus and newborn affected by maternal use of drugs of addiction confirmed
2 715 deaths with diagnosis fetus and newborn affected by maternal use of drugs of addiction
1% mortality rate associated with the disease fetus and newborn affected by maternal use of drugs of addiction
Diagnosis fetus and newborn affected by maternal use of drugs of addiction is diagnosed Men are 5.67% more likely than Women
173 513
Men receive the diagnosis fetus and newborn affected by maternal use of drugs of addiction
2 715 (1.6 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
154 879
Women receive the diagnosis fetus and newborn affected by maternal use of drugs of addiction
0 (less than 0.1%)Died from this diagnosis.
Risk Group for the Disease fetus and newborn affected by maternal use of drugs of addiction - Men and Women aged 0
In Men diagnosis is most often set at age 0-1
Less common in men the disease occurs at Age 0-95+Less common in women the disease occurs at Age 0-5, 10-95+
In Women diagnosis is most often set at age 0-1, 5-9
Disease Features fetus and newborn affected by maternal use of drugs of addiction
Absence or low individual and public risk
Fetus and newborn affected by maternal use of drugs of addiction - what does this mean
Fetus and newborn affected by maternal use of drugs of addiction occurs when a pregnant woman uses drugs like opioids, cocaine, and marijuana, which can cross the placenta and affect the baby's development in the womb. this can lead to a range of adverse effects, including physical and cognitive impairments, as well as an increased risk of premature birth.
What happens during the disease - fetus and newborn affected by maternal use of drugs of addiction
The pathogenesis of a fetus or newborn affected by maternal use of drugs of addiction is a complex process. maternal drug use can lead to a range of adverse effects in the fetus, including impaired placental function, reduced oxygen and nutrient delivery, and increased risk of preterm labor and delivery. in addition, the drugs themselves can cross the placental barrier and cause direct toxicity to the fetus, resulting in a range of physical and neurological deficits. these deficits can range from mild to severe, depending on the type and amount of drug used by the mother.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Obtain a detailed maternal medical and drug history.
- Examine the mother for signs of drug use.
- Perform a physical examination of the fetus/newborn.
- Order laboratory tests to detect drug metabolites in the mother and infant.
- Order imaging studies to assess fetal/neonatal organ development.
- Evaluate the infant for signs of withdrawal or toxicity.
- Perform a neurological assessment of the infant.
- Monitor the infant's growth and development.
Treatment and Medical Assistance
Main Goal: To ensure the health and safety of the fetus and newborn affected by maternal use of drugs of addiction.
- Close monitoring of the mother's health and drug use during pregnancy
- Regular assessments of the fetus and newborn's health
- Provide medical care and drug treatment to the mother, if necessary
- Provide appropriate nutrition and hydration to the mother and fetus/newborn
- Provide appropriate care and support to the mother and fetus/newborn
- Provide appropriate mental health and social services to the mother and fetus/newborn
- Provide appropriate educational services to the mother and fetus/newborn
- Provide appropriate follow-up care to the mother and fetus/newborn
9 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Fetus and newborn affected by maternal use of drugs of addiction - Prevention
The best way to prevent a fetus and newborn from being affected by maternal use of drugs of addiction is to ensure that pregnant women are provided with comprehensive, evidence-based substance abuse treatment and support services. this includes counseling, medication-assisted treatment, and social services to help women achieve sobriety before, during, and after pregnancy. additionally, pregnant women should be monitored closely for signs of relapse and provided with appropriate interventions when needed.